- NZD/USD rejects Thursday’s pullback near intraday high, consolidates weekly losses.
- New Zealand PM Ardern suspends quarantine free travel with Australia.
- Mixed covid updates, vaccine news jostle stimulus optimism amid a quiet session.
- Preliminary PMIs for July eyed, risk catalysts stay on driver’s seat.
NZD/USD stays on the front foot around 0.6985, up 0.27% intraday, amid early Friday. In doing so, the kiwi pair reverses the previous day’s downside move near the day’s high as market sentiment improves during a sluggish Asian session.
Although the off in Japan and a light calendar elsewhere in Asia bore traders, optimism among the US policymakers over the stimulus and a lack of worrisome numbers from some of the crucial Aussie states back the pair buyers.
Also, New Zealand’s comparatively better covid conditions than the rest of the global and increasing odds of RBNZ rate hike during late 2021, to be the first developed back in that action, favor NZD/USD bulls.
Australia’s Victoria registers half of the covid counts to 14 but worrisome signs erupt from New South Wales (NSW) as Premier Gladys Berejiklian said, per ABC News, “The numbers are not going in the direction we were hoping”. On the same line, the virus-led death tolls are rising in the UK with scientists warning of the return of the lockdown in three weeks.
To safeguard the nation, New Zealand Prime Minister Jacinda Ardern suspended quarantine free travel with Australia for eight weeks.
It should be noted that the US vaccine panel’s support for COVID-19 booster shots and policymaker’s optimism over further stimulus, not to forget the relief in altering the US debt limits, also favor the sentiment.
Amid these plays, S&P 500 Futures rise 0.35% intraday whereas the US 10-year Treasury yields remain positive around 1.28% by the press time.
Moving on, NZD/USD traders will keep their eyes on the risk catalysts and wait for the US PMIs for July for fresh impulse. However, the bulls are likely to keep the reins as RBNZ is ahead of the curve.
In addition to the 21-DMA near 0.6990, a two-month-old descending resistance line around 0.7010 also challenges NZD/USD bulls before directing them to the key 200-DMA hurdle of 0.7088. Meanwhile, 0.6920 becomes a near-term important support to watch during the quote’s pullback moves. It’s worth noting that bullish MACD and sturdy RSI back the buyers of late.
Additional important levels
|Today last price||0.698|
|Today Daily Change||0.0014|
|Today Daily Change %||0.20%|
|Today daily open||0.6966|
|Previous Daily High||0.6987|
|Previous Daily Low||0.6947|
|Previous Weekly High||0.7046|
|Previous Weekly Low||0.6917|
|Previous Monthly High||0.7289|
|Previous Monthly Low||0.6923|
|Daily Fibonacci 38.2%||0.6962|
|Daily Fibonacci 61.8%||0.6972|
|Daily Pivot Point S1||0.6946|
|Daily Pivot Point S2||0.6926|
|Daily Pivot Point S3||0.6906|
|Daily Pivot Point R1||0.6986|
|Daily Pivot Point R2||0.7007|
|Daily Pivot Point R3||0.7026|
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.